John Brancaccio

Insider Reports History

Entity
Individual
Location
C/O Tamir Biotechnology, Inc., 11 Deer Park Drive, Suite 204, Monmouth Junction, NJ
Signature
/s/ John Brancaccio
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Brancaccio:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cardiff Oncology, Inc. Former Director Stock Options 125K $326K $2.60 Jun 9, 2022 Direct
OKYO Pharma Ltd Director Ordinary Shares 16.7K $25K $1.50 Sep 15, 2023 Direct
Hepion Pharmaceuticals, Inc. Chairman, Director Stock Options 99.6K Feb 19, 2024 Direct

Insider Reports Filed by John Brancaccio

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HEPA Hepion Pharmaceuticals, Inc. Feb 19, 2024 1 $0 4 Feb 21, 2024 Chairman, Director
OKYO OKYO Pharma Ltd Sep 15, 2023 1 $25K 4 Sep 28, 2023 Director
CRDF Cardiff Oncology, Inc. Jun 9, 2022 9 $0 4 Jun 9, 2022 Former Director
OKYO OKYO Pharma Ltd May 16, 2022 0 $0 3 May 16, 2022 Director
CRDF Cardiff Oncology, Inc. Mar 9, 2022 1 $0 4 Mar 10, 2022 Director
ACMSY Accustem Sciences Inc. Dec 1, 2021 0 $0 3 Dec 3, 2021 Director
CRDF Cardiff Oncology, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
HEPA Hepion Pharmaceuticals, Inc. May 18, 2021 1 $0 4 May 20, 2021 Director